Key facts
- Cross Sync’s last known valuation is $11.5M (Oct 2025).
- It has raised $6.9M; the latest was Later Stage VC ($5.3M) in Oct 2025.
- Notable investors include Mizuho Capital, Japan External Trade Organization, Sony Innovation Fund, Intellectual Property Acceleration Program for Startups, Mirai Creation Capital — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Cross Sync
- ·The full record, as it builds
Funding rounds
No funding rounds for Cross Sync are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cross Sync
Developer of a healthcare technology intended to perform advanced patient monitoring and information sharing. The company's technology utilizes artificial intelligence to accelerate information sharing by aggregating, analyzing, and visualizing medical information scattered in the medical field, enabling patients to get proper medical monitoring around the clock.
- Sector
- Healthcare
- HQ
- Yokohama, Japan
- Founded
- 2019
- Employees
- 4
- Website
- cross-sync.co.jp/
- Ownership
- Privately Held (backing)
Cross Sync doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cross Sync shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cross Sync in its N-PORT filings yet. We sweep new filings monthly.